Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1952 1
1962 2
1963 2
1964 1
1966 3
1967 3
1968 2
1969 1
1970 3
1971 1
1972 2
1973 4
1974 5
1975 4
1976 4
1977 11
1978 3
1979 3
1980 7
1981 3
1982 5
1983 8
1984 9
1985 8
1986 23
1987 29
1988 26
1989 50
1990 41
1991 43
1992 68
1993 60
1994 82
1995 73
1996 122
1997 100
1998 171
1999 150
2000 211
2001 245
2002 284
2003 337
2004 411
2005 459
2006 519
2007 654
2008 713
2009 780
2010 1046
2011 1141
2012 1338
2013 1366
2014 1486
2015 1532
2016 1518
2017 1478
2018 1482
2019 1548
2020 1618
2021 1592
2022 1476
2023 1338
2024 1361
2025 1324
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,348 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation: The ALONE-AF Randomized Clinical Trial.
Kim D, Shim J, Choi EK, Oh IY, Kim J, Lee YS, Park J, Ko JS, Park KM, Sung JH, Park HW, Park HS, Kim JY, Kang KW, Kim D, Park JK, Kim DH, Kim JB, Yu HT, Kim TH, Uhm JS, Pak HN, Joung B; ALONE-AF Investigators. Kim D, et al. Among authors: park km. JAMA. 2025 Oct 14;334(14):1246-1254. doi: 10.1001/jama.2025.14679. JAMA. 2025. PMID: 40886309 Clinical Trial.
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis.
Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H, Kim HS, Kang J, Park KW, Pettersen AÅ, Woodward M, Bhatt DL, Calabrò P, Angiolillo DJ, Mehran R, Song YB, Hahn JY. Valgimigli M, et al. Among authors: park kw. Lancet. 2025 Sep 13;406(10508):1091-1102. doi: 10.1016/S0140-6736(25)01562-4. Epub 2025 Aug 31. Lancet. 2025. PMID: 40902613
DNA Methylation-Based Classification of Kidney Neoplasms.
Papanicolau-Sengos A, Singh O, Park K, Snuderl M, Tretiakova M, Merino M, Stohr B, Simko J, Deng FM, Chan E, Wu J, Barreto J, Gupta R, Park B, Turakulov R, Abdullaev Z, Solomon DA, Aldape K. Papanicolau-Sengos A, et al. Among authors: park k. Mod Pathol. 2025 Nov;38(11):100884. doi: 10.1016/j.modpat.2025.100884. Epub 2025 Sep 10. Mod Pathol. 2025. PMID: 40939817
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lim S, Buranapin S, Bao X, Quiroga M, Park KH, Kang JH, Rinnov AR, Suwanagool A. Lim S, et al. Among authors: park kh. Lancet Diabetes Endocrinol. 2025 Oct;13(10):838-847. doi: 10.1016/S2213-8587(25)00164-0. Epub 2025 Aug 15. Lancet Diabetes Endocrinol. 2025. PMID: 40825340 Clinical Trial.
Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers.
Blechter B, Wang X, Dai J, Karsonaki C, Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Hung RJ, Chen K, Shu XO, Kim YT, Choudhury PP, Williams J, Landi MT, Lin D, Zheng W, Yin Z, Zhou B, Wang J, Seow WJ, Song L, Chang IS, Hu W, Chien LH, Cai Q, Hong YC, Kim HN, Wu YL, Wong MP, Richardson BD, Li S, Zhang T, Breeze C, Wang Z, Bassig BA, Kim JH, Albanes D, Wong Sm JY, Shin MH, Chung LP, Yang Y, Zheng H, Dai H, Yatabe Y, Zhang XC, Kim YC, Caporaso NE, Chang J, Ho JCM, Daigo Y, Momozawa Y, Kamatani Y, Kobayashi M, Okubo K, Honda T, Hosgood HD, Kunitoh H, Watanabe SI, Miyagi Y, Matsumoto S, Horinouchi H, Tsuboi M, Hamamoto R, Goto K, Takahashi A, Goto A, Minamiya Y, Hara M, Nishida Y, Takeuchi K, Wakai K, Matsuda K, Murakami Y, Shimizu K, Suzuki H, Saito M, Ohtaki Y, Tanaka K, Wu T, Wei F, Machiela MJ, Kim YH, Oh IJ, Lee VHF, Chang GC, Chen KY, Su WC, Chen YM, Seow A, Park JY, Kweon SS, Gao YT, Liu J, Schwartz AG, Houlston R, Gorlov IP, Wu X, Yang P, Lam S, Tardon A, Chen C, Bojesen SE, Johansson M, Risch A, Bickeböller H, Ji BT, Wichmann HE, Christiani DC, Rennert G, Arnold SM, Brennan P, McKay J, Field JK, Davies MPA, Shete SS, Le Marchand L, Liu G, Andrew AS, Kiemeney LA, Zienolddiny… See abstract for full author list ➔ Blechter B, et al. Among authors: park kh. J Natl Cancer Inst. 2025 Oct 1:djaf272. doi: 10.1093/jnci/djaf272. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 41032288
Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.
Mittmann G, Laiouar-Pedari S, Mehrtens HA, Haggenmüller S, Bucher TC, Chanda T, Gaisa NT, Wagner M, Klamminger GG, Rau TT, Neppl C, Compérat EM, Gocht A, Haemmerle M, Rupp NJ, Westhoff J, Krücken I, Seidl M, Schürch CM, Bauer M, Solass W, Tam YC, Weber F, Grobholz R, Augustyniak J, Kalinski T, Hörner C, Mertz KD, Döring C, Erbersdobler A, Deubler G, Bremmer F, Sommer U, Brodhun M, Griffin J, Lenon MSL, Trpkov K, Cheng L, Chen F, Levi A, Cai G, Nguyen TQ, Amin A, Cimadamore A, Shabaik A, Manucha V, Ahmad N, Messias N, Sanguedolce F, Taheri D, Baraban E, Jia L, Shah RB, Siadat F, Swarbrick N, Park K, Hassan O, Sakhaie S, Downes MR, Miyamoto H, Williamson SR, Holland-Letz T, Wies C, Schneider CV, Kather JN, Tolkach Y, Brinker TJ. Mittmann G, et al. Among authors: park k. Nat Commun. 2025 Oct 8;16(1):8959. doi: 10.1038/s41467-025-64712-4. Nat Commun. 2025. PMID: 41062516 Free PMC article.
Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries.
Huerta-Chagoya A, Kim J, Mandla R, Lu Y, Suzuki K, Petty LE, Ng HK, Choi J, Lee S, Rout M, Lin K, Adair LS, Adeyemo A, Ahsan H, Akiyama M, An P, Anand SS, Becker DM, Bertoni AG, Bian Z, Bielak LF, Blangero J, Boehnke M, Bottinger EP, Bowden DW, Bragg F, Brody JA, Buchanan TA, Cade BE, Chai JF, Chambers JC, Chandak GR, Chang LC, Chang KM, Chee ML, Chen CH, Chen YT, Chen Z, Chen YI, Chen J, Chen G, Chen SH, Chen WM, Cheng CY, Cho YS, Choi HS, Chuang LM, Cruz M, Cushman M, Das SK, DeFronzo RA, deSilva HJ, Dimitrov L, Doumatey AP, Du S, Duan Q, Duggirala R, Emery LS, Engert JC, Evans DS, Evans MK, Finer S, Florez JC, Floyd JS, Fornage M, Frankel EG, Freedman BI, García-García L, Genter P, Gerstein HC, Goodarzi MO, Gordon-Larsen P, Graff M, Gross M, Guo Y, Guo X, Hai Y, Hanis CL, Hayes M, Horikoshi M, Howard AG, Hsu S, Hsueh W, Huang W, Huang M, Hung YJ, Hwang MY, Hwu CM, Ichihara S, Igase M, Ipp E, Islam MT, Isono M, Jang HM, Jasmine F, Jonas JB, Joo YY, Kabagambe E, Kadowaki T, Kamatani Y, Kandeel FR, Kardia SLR, Karlson EW, Kasturiratne A, Kato N, Katsuya T, Kaur V, Kawaguchi T, Keaton JM, Kho AN, Khor CC, Kibriya M, Kim BJ, Koh WP, Kohara K, Kooner JS, Kooperberg C, Kreienkamp RJ, … See abstract for full author list ➔ Huerta-Chagoya A, et al. Among authors: park ks. medRxiv [Preprint]. 2025 Jul 23:2025.07.21.25331778. doi: 10.1101/2025.07.21.25331778. medRxiv. 2025. PMID: 40778152 Free PMC article. Preprint.
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseases.
Won W, Lee EH, Gotina L, Chun H, Lee JH, Bhalla M, Park U, Kim D, Kim TY, Choi JW, Kim Y, Park SJ, Lim J, Park JH, Kim HJ, Heo JY, Chung W, Oh MJ, An HJ, Lee J, Oh SJ, Ryu H, Pae AN, Park KD, Lee CJ. Won W, et al. Among authors: park kd. Signal Transduct Target Ther. 2025 Aug 22;10(1):270. doi: 10.1038/s41392-025-02366-w. Signal Transduct Target Ther. 2025. PMID: 40846833 Free PMC article.
25,348 results
You have reached the last available page of results. Please see the User Guide for more information.